CYTOSORBENTS CORPORATION Stock Issued During Period, Shares, Other
CYTOSORBENTS CORPORATION (CTSO) reported Stock Issued During Period, Shares, Other of 68.79 thousand shares for the 1-month period ending 2018-05-23, per its 10-K filed 2020-03-05.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesOther · last filed 2020-03-05
- 2018-05-23: Stock Issued During Period, Shares, Other 1 month 68.79K shares.
| Period end | Stock Issued During Period, Shares, Other 1 month |
|---|---|
| 2018-05-23 | 68.79K shares 10-K · filed 2020-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |